Novartis (NYSE: NVS) China has announced the establishment of a health development fund, a significant move aimed at bolstering health development, advancing societal improvement, and facilitating common prosperity in China through national-level charitable activities. Registered at the Boao Lecheng Medical Tourism Pilot Zone, this initiative makes Novartis the first in the pharmaceutical industry to set up such a fund in the country.
Fund Establishment and Strategic Partnership
The establishment of the fund is attributed to the policy and system advantages in Hainan, as highlighted by Dan Brindle, president of Novartis China. This move also marks another milestone in the strategic partnership between Novartis and Lecheng, further solidifying their collaborative efforts to enhance health and societal development in the region.-Fineline Info & Tech
